Cargando…
Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: A meta-analysis
BACKGROUND: Venous thromboembolism (VTE) poses a significant health risk to patients with morbid obesity or high body weight. Non-vitamin K antagonist oral anticoagulants (NOACs) are emerging treatments, but their effectiveness and safety compared with vitamin K antagonists (VKAs) in this population...
Autores principales: | Zhang, Hongxia, Xie, Hua, Wang, Xiaoyan, Zhu, Zonghong, Duan, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489198/ https://www.ncbi.nlm.nih.gov/pubmed/37682131 http://dx.doi.org/10.1097/MD.0000000000035015 |
Ejemplares similares
-
Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis
por: Michael, Faith, et al.
Publicado: (2021) -
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
por: Deng, Yuqing, et al.
Publicado: (2019) -
Efficacy and safety of antithrombotic therapy with non-vitamin K
antagonist oral anticoagulants after transcatheter aortic valve replacement: a
systematic review and meta-analysis
por: An, Qing, et al.
Publicado: (2021) -
Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
por: Joosten, Linda P T, et al.
Publicado: (2023) -
Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
por: Pan, Kuo‐Li, et al.
Publicado: (2017)